<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of the Russian academy of medical sciences</journal-id><journal-title-group><journal-title xml:lang="en">Annals of the Russian academy of medical sciences</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российской академии медицинских наук</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-6047</issn><issn publication-format="electronic">2414-3545</issn><publisher><publisher-name xml:lang="en">"Paediatrician" Publishers LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">346</article-id><article-id pub-id-type="doi">10.15690/vramn.v67i2.123</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ENDOCRINOLOGY: CURRENT ISSUES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>АКТУАЛЬНЫЕ ВОПРОСЫ ЭНДОКРИНОЛОГИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">CLINICAL SIGNIFICANCE OF INSULIN RESISTANCE SYNDROME IN DEVELOPMENT OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH PRIMARY GOUT</article-title><trans-title-group xml:lang="ru"><trans-title>КЛИНИЧЕСКОЕ ЗНАЧЕНИЕ СИНДРОМА ИНСУЛИНОРЕЗИСТЕНТНОСТИ В РАЗВИТИИ ДИСФУНКЦИИ ЭНДОТЕЛИЯ У БОЛЬНЫХ ПЕРВИЧНОЙ ПОДАГРОЙ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kushnarenko</surname><given-names>N. N.</given-names></name><name xml:lang="ru"><surname>Кушнаренко</surname><given-names>Н. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>кандидат медицинских наук, заведующая кафедрой внутренних болезней стома- тологического и педиатрического факультетов Читинской государственной медицинской академии.</p></bio><email>pochta@medacadem.chita.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Govorin</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Говорин</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>доктор медицинских наук, профессор, заслуженный врач РФ, ректор ГОУ ВПО Читинской государственной медицинской академии, заведующий кафедрой факультетской терапии.</p></bio><email>pochta@medacadem.chita.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shcherbakova</surname><given-names>O. A.</given-names></name><name xml:lang="ru"><surname>Щербакова</surname><given-names>О. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>pochta@medacadem.chita.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sotnikova</surname><given-names>S. G.</given-names></name><name xml:lang="ru"><surname>Сотникова</surname><given-names>С. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>pochta@medacadem.chita.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ivanitskaya</surname><given-names>O. V.</given-names></name><name xml:lang="ru"><surname>Иваницкая</surname><given-names>О. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>pochta@medacadem.chita.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Chita State Medical Academy Ministry of Healthcare and Social development of Russia, Chita, Russia</institution></aff><aff><institution xml:lang="ru">ГОУ ВПО «Читинская государственная медицинская академия» Минздравсоцразвития России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2012-02-22" publication-format="electronic"><day>22</day><month>02</month><year>2012</year></pub-date><volume>67</volume><issue>2</issue><issue-title xml:lang="en">Vestnik Rossiiskoi akademii medetsinskikh nauk / Annals of the Russian academy of medical sciences</issue-title><issue-title xml:lang="ru">Вестник Российской академии медицинских наук</issue-title><fpage>60</fpage><lpage>63</lpage><history><date date-type="received" iso-8601-date="2015-08-07"><day>07</day><month>08</month><year>2015</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2012, "Paediatrician" Publishers LLC</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2012, Издательство "Педиатръ"</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="en">"Paediatrician" Publishers LLC</copyright-holder><copyright-holder xml:lang="ru">Издательство "Педиатръ"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://vestnikramn.spr-journal.ru/jour/about/submissions</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikramn.spr-journal.ru/jour/article/view/346">https://vestnikramn.spr-journal.ru/jour/article/view/346</self-uri><abstract xml:lang="en"><p><italic>Endothelial function has been studied in 175 males with primary gout. It has been established that incidence of endothelial dysfunction in patients with primary gout was associated with the clinical course and was marked most of all in patients who had a chronic gout. The correlations found between the parameters of endothelial dysfunction and impaired carbohydrate metabolism suggest close link and coordination between the above processes which contribute greatly to development and progress of atherosclerosis in such patients.</italic></p></abstract><trans-abstract xml:lang="ru"><p><italic>В работе представлены результаты изучения функционального состояния эндотелия у 175 мужчин, страдающих первичной подагрой.</italic><italic> Установлено, что частота развития эндотелиальной дисфункции у больных первичной подагрой зависела от клинического течения заболе</italic><italic>вания и была наиболее выраженной у пациентов с хронической подагрой. Установленные корреляционные взаимосвязи между показателя</italic><italic>ми, характеризующими наличие эндотелиальной дисфункции и нарушение углеводного обмена, позволяют говорить о взаимной сопряженно</italic><italic>сти изученных процессов, которые вносят существенный вклад в развитие и прогрессирование атеросклероза у данной категории больных.</italic></p></trans-abstract><kwd-group xml:lang="en"><kwd>gout</kwd><kwd>endothelial dysfunction</kwd><kwd>insulin resistance</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>подагра</kwd><kwd>эндотелиальная дисфункция</kwd><kwd>инсулинорезистентность</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1.	Namakanov B.A., Rasulov M.M. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular therapy and prophylaxis. 2005; 4 (6): 98−101.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2.	Trusov V.V., Filimonov M.A., Aksenov K.V. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular therapy and prophylaxis. 2005; 4 (6): 62−66.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3.	Petrischev N.N. Disfunktsiya endoteliya: prichiny, mekhanizmy, farmakologicheskaya korrektsiya [Endothelial Dysfunction: Etiology, Mechanisms, Pharmacological Correction]. St. Petersburg, SPbGMU, 2003. 184 p.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4.	Furchgott R.F, Vanhoutte P.M. Еndothelium-derived relaxing and contracting factors. FASEB J. 1989; 3: 2007−2018.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5.	Rackley C.E. Endothelial UpToDate. 2002; 10. Available at: http://www.uptodate.com</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6.	Kanellis J., Kang D.H. Uric acid as a mediator of endothelial dysfunction, inflammation and vascular diseas. Semin. Nephrol. 2005; 25: 39−42.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7.	Lapkina N.A., Baranov A.A., Barskova V.G. et al. Ter. arhiv = Therapeutic archive. 2005; 6: 62−65.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8.	Laakso M., Sarlund H., Mykkanen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subject with varying degrees of glucose tolerance. Arteriosclerosis. 1990; 10: 223−231.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9.	Wallace К.L., Riedel A.A., Joseph-Ridge N. et al. Increasing prevalence of gout and hyperuricemia over 10 years among older adult in a managed care population. J. Rheumatol. 2004; 31: 1582−1587.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10.	Ivanova O.V., Rogoza A.N., Balahonova T.V. et al. Kardiologiya = Cardiology. 1998; 3: 37−41.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11.	Hollenbeck C.B., Chen N., Chen Y.-D. I., Reaven G.М. Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes. 1984; 33: 460−463.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12.	Rojtberg G.E. Metabolicheskii sindrom [Metabolic Syndrome]. Moscow, 2007.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13.	Zatejschikova A.A., Zatejschikov D.A. Kardiologiya = Cardiology. 1998; 9: 68−76.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14.	ESH-ESC Guidelines Committee. ESH-ESC guidelines for the management of arterial hypertension. J. Hypertens. 2007; 21: 1011−1053.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15.	Vogel R.A. Coronary risk factors, endothelial function, and atherosclerosis: a review. Clin. Cardiol. 1997; 20: 426−432.</mixed-citation></ref></ref-list></back></article>
